Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (101-110 of 223) with videos related to

Pageof 23
Sort By:
European Journal of Gastroenterology & Hepatology|November 27, 2009
Consensus on the current use of sorafenib for the treatment of hepatocellular carcinomaMarkus Peck-Radosavljevic, Tim F Greten, Johannes Lammer, et al.
Immunology|August 20, 2009
Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinomaFei Zhao, Benjamin Vermeer, Ulrich Lehmann, et al.
United European Gastroenterology Journal|June 12, 2014
Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results databaseTobias Eggert, Katherine A McGlynn, Austin Duffy, et al.
Immunology|August 20, 2009
Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinomaFei Zhao, Sonja Obermann, Reinhard von Wasielewski, et al.
Nature Reviews. Gastroenterology & Hepatology|January 25, 2023
Immunology and immunotherapy of cholangiocarcinomaTim F Greten, Robert Schwabe, Nabeel Bardeesy, et al.
Nature Reviews. Gastroenterology & Hepatology|January 29, 2021
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinomaJosep M Llovet, Thierry De Baere, Laura Kulik, et al.
Nature Reviews. Clinical Oncology|September 19, 2023
Biomarkers for immunotherapy of hepatocellular carcinomaTim F Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Hepatology (Baltimore, Md.)|September 15, 2019
Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum RetentionBryan D Fleming, Daniel J Urban, Matthew D Hall, et al.
Immunology|February 7, 2012
S100A9 a new marker for monocytic human myeloid-derived suppressor cellsFei Zhao, Bastian Hoechst, Austin Duffy, et al.
Gastroenterology|November 28, 2002
Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesisFlorian R Greten, Christoph K Weber, Tim F Greten, et al.
Pageof 23

Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
European Journal of Gastroenterology & Hepatology|November 27, 2009
Consensus on the current use of sorafenib for the treatment of hepatocellular carcinomaMarkus Peck-Radosavljevic, Tim F Greten, Johannes Lammer, et al.
Immunology|August 20, 2009
Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinomaFei Zhao, Benjamin Vermeer, Ulrich Lehmann, et al.
United European Gastroenterology Journal|June 12, 2014
Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results databaseTobias Eggert, Katherine A McGlynn, Austin Duffy, et al.
Immunology|August 20, 2009
Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinomaFei Zhao, Sonja Obermann, Reinhard von Wasielewski, et al.
Nature Reviews. Gastroenterology & Hepatology|January 25, 2023
Immunology and immunotherapy of cholangiocarcinomaTim F Greten, Robert Schwabe, Nabeel Bardeesy, et al.
Nature Reviews. Gastroenterology & Hepatology|January 29, 2021
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinomaJosep M Llovet, Thierry De Baere, Laura Kulik, et al.
Nature Reviews. Clinical Oncology|September 19, 2023
Biomarkers for immunotherapy of hepatocellular carcinomaTim F Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Hepatology (Baltimore, Md.)|September 15, 2019
Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum RetentionBryan D Fleming, Daniel J Urban, Matthew D Hall, et al.
Immunology|February 7, 2012
S100A9 a new marker for monocytic human myeloid-derived suppressor cellsFei Zhao, Bastian Hoechst, Austin Duffy, et al.
Gastroenterology|November 28, 2002
Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesisFlorian R Greten, Christoph K Weber, Tim F Greten, et al.
Pageof 23